Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Army
Queensland Health
US Department of Justice
Johnson and Johnson
Harvard Business School

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,569,652

« Back to Dashboard

Summary for Patent: 5,569,652

Title: Dihydrospirorenone as an antiandrogen
Abstract:Dihydrospirorenone, ##STR1## preferably together with an estrogen, can be used for the production of a pharmaceutical agent suitable for treatment of hormonal irregularities during premenopause (menstruation stabilization), for hormonal substitution therapy during menopause, for treatment of androgen-induced disorders and/or for contraception.
Inventor(s): Beier; Sybille (Berlin, DE), Elger; Walter (Berlin, DE), Nishino; Yukishige (Berlin, DE), Wiechert; Rudolf (Berlin, DE)
Assignee: Schering Aktiengesellschaft (Berlin, DE)
Application Number:08/162,387
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 5,569,652

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany39 16 112.9May 16, 1989

International Patent Family for Patent: 5,569,652

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria154881► Subscribe
Australia5509490► Subscribe
Australia642876► Subscribe
Brazil1101055► Subscribe
Canada2016780► Subscribe
China1033948► Subscribe
China1047299► Subscribe
German Democratic Republic294417► Subscribe
Germany122004000006► Subscribe
Germany3916112► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: